Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RARA | P10276 | 3/20 | 0.44 |
| ▸ | RARB | P10826 | 3/20 | 0.44 |
| ▸ | RARG | P13631 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | RXRA | P19793 | 2/20 | 0.43 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.43 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13710832 | 0.84 | ALDH1A1 (0.56) | ALDH1A1POLBLMNAHPGDKMT2A | |
| SCHEMBL4910902 | 0.81 | ALDH1A1 (0.68) | ALDH1A1TDP1POLBGLAL3MBTL1 | |
| SCHEMBL8588438 | 0.79 | ALDH1A1 (0.65) | ALDH1A1TDP1POLBGLAL3MBTL1 | |
| SCHEMBL8826946 | 0.79 | ESR1 (0.67) | ALDH1A1TDP1POLBGLAL3MBTL1 | |
| SCHEMBL8826952 | 0.79 | ESR1 (0.67) | ALDH1A1TDP1POLBGLAL3MBTL1 | |
| SCHEMBL10964033 | 0.79 | EGFR (0.64) | ALDH1A1POLBLMNAHPGDKMT2A | |
| SCHEMBL10964041 | 0.79 | EGFR (0.64) | ALDH1A1POLBLMNAHPGDKMT2A | |
| SCHEMBL5168254 | 0.78 | MCL1 (0.50) | ALDH1A1POLBL3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL679854 | 0.78 | MCL1 (0.50) | ALDH1A1POLBL3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL13710834 | 0.78 | ALDH1A1 (0.50) | ALDH1A1POLBLMNAHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109313198-B | Background blockers for binding assays | 雷度米特图尔库公司 | 2022-07-15 | — | — | CN | disclosed |
| US-20220204565-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | UNIV DREXEL (US) | 2022-06-30 | — | — | US | disclosed |
| EP-3990446-A1 | NOVEL LUMINESCENT LANTHANIDE CHELATE REPORTERS, BIOSPECIFIC BINDING REACTANTS LABELLED WITH NOVEL LUMINESCENT LANTHANIDE CHELATE REPORTERS AND THEIR USE | Radiometer Turku Oy (FI) | 2022-05-04 | — | — | EP | disclosed |
| CN-114026070-A | Novel luminescent lanthanide chelate reporter molecules, biospecific binding reactants labeled with novel luminescent lanthanide chelate reporter molecules and uses thereof | 雷度米特图尔库公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-107074815-B | Novel chromophoric structures for macrocyclic lanthanide chelates | 雷度米特图尔库公司 | 2021-06-22 | — | — | CN | disclosed |
| EP-3768665-A1 | LUMINESCENT LANTHANIDE CHELATES AND THEIR USE | Radiometer Turku Oy (FI) | 2021-01-27 | — | — | EP | disclosed |
| WO-2020260384-A1 | NOVEL LUMINESCENT LANTHANIDE CHELATE REPORTERS, BIOSPECIFIC BINDING REACTANTS LABELLED WITH NOVEL LUMINESCENT LANTHANIDE CHELATE REPORTERS AND THEIR USE | RADIOMETER TURKU OY (FI) | 2020-12-30 | — | — | WO | disclosed |
| US-20190375792-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-12-12 | — | — | US | disclosed |
| WO-2019179798-A1 | LUMINESCENT LANTHANIDE CHELATES AND THEIR USE | RADIOMETER TURKU OY (FI) | 2019-09-26 | — | — | WO | disclosed |
| US-20190175688-A1 | Cyclic Peptides and Methods Using Same | UNIV DREXEL (US) | 2019-06-13 | — | — | US | disclosed |
| EP-1402263-B1 | TWO-PHOTON ABSORBING DIPYRROMETHENEBORON DIFLUORIDE DYES AND THEIR APPLICATIONS | ARCTIC DIAGNOSTICS OY (FI) | 2009-10-28 | — | — | EP | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
| CN-1852989-A | PKNB kinase and PSTP phosphatase and methods of identifying inhibitory substances | PASTEUR INSTITUT (FR) | 2006-10-25 | — | — | CN | disclosed |
| WO-2006065809-A2 | HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| CN-1257408-C | Two-photon absorption dipyrromethene boron difluoride dye and application thereof | ARCTIC DIAGNOSTICS OY (FI) | 2006-05-24 | — | — | CN | disclosed |
| CN-1526071-A | Two-photon absorption dipyrromethene boron difluoride dye and application thereof | ����˹ҽ������˾ | 2004-09-01 | — | — | CN | disclosed |
| EP-1007548-A4 | TSETSE THROMBIN INHIBITOR | UNIV YALE (US) | 2002-07-03 | — | — | EP | disclosed |
| EP-1007548-A1 | TSETSE THROMBIN INHIBITOR | Yale University (US) | 2000-06-14 | — | — | EP | disclosed |
| US-6036958-A | POLYPEPTIDES WITH AMINO ACID SEQUENCES | YALE UNIVERSITY (US) | 2000-03-14 | — | — | US | disclosed |
| WO-1997043309-A1 | TSETSE THROMBIN INHIBITOR | YALE UNIVERSITY (US) | 1997-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190375792-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | VIP, CCL5, ZC3HAV1 | ALDH1A1 3108/4885TDP1 2298/4885POLB 1122/4885 |
| US-20220204565-A1 | Cyclic Peptide Antiviral Agents and Methods Using Same | ZC3HAV1, VIP, LNPEP | ALDH1A1 4630/4885TDP1 2941/4885POLB 981/4885 |
| US-20190175688-A1 | Cyclic Peptides and Methods Using Same | VIP, NGLY1, LNPEP | ALDH1A1 4603/4885TDP1 4293/4885POLB 3543/4885 |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | ALDH1A1 4332/4885TDP1 4183/4885POLB 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.